Found 7 matching trials
A Study of LY03003 in Patients With Early-stage Parkinson's Disease PHASE1 This study is to characterize the pharmacokinetics and to evaluate the safe...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro PHASE1 Phase 1, single center study to assess pharmacokinetic profiles of rotigoti...
Show More Location
Pharmaron CPC, Inc.
Learn More & Join Trial
A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003 PHASE1 This study is to evaluate the human tolerance and pharmacokinetics of LY030...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD PHASE3 This study is to evaluate the effictiveness and safety of Ly03003 following...
Show More Location
Xuanwu Hospital Capital Medical University
Learn More & Join Trial
A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers PHASE1 This is a randomized, open-label, 2-sequence, 2-treatment cross-over study ...
Show More Location
Pharmaceutical Research Associates, Inc.
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD PHASE1 This study is to evaluate the pharmacokinetics and safety of LY03003 in pat...
Show More Location
Xuanwu Hospital Capital Medical University
Learn More & Join Trial
A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease PHASE1 This study is to evaluate the safety and tolerability and to characterize t...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial